Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol)
Andreoli, C.; Fiorentino, F.; Lenzi, G.
Quaderni di Clinica Ostetrica E Ginecologica 25(1): 15-28
1970
ISSN/ISBN: 0033-491X PMID: 5523807 Document Number: 24194
Document emailed within 1 workday
Related Documents
Vickers, A.E.; Nelson, K.; McCoy, Z.; Lucier, G.W. 1989: Changes in estrogen receptor, DNA ploidy, and estrogen metabolism in rat hepatocytes during a two-stage model for hepatocarcinogenesis using 17 alpha-ethinylestradiol as the promoting agent Cancer Research 49(23): 6512-6520Sabra, A.; Bonnar, J. 1983: Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel Journal of Reproductive Medicine 28(1 Suppl): 85-91
Kirkman, R.J.E.; Bounds, W.; Colliver, D.; Guillebaud, J.; Jackson, R.; Barden, E. 1990: Practical experience in the uk with an estrogen progestogen vaginal contraceptive ring Advances in Contraception 6(4): 292
Sartoretto, J.N.; Ortega-Recio, J.C.; Moraes, R.; Filho, F.N. 1977: Clinical studies with a low dose estrogen-progestogen combination Contraception 15(5): 563-570
Rockel, P.; Hoffmann, B.; Kyrein, H.J. 1978: Relationships between the size of ovarian follicles, the binding capacity of uterine estrogen receptors and estrogen concentrations in the follicular fluid and urine of calves under estrogen therapy Berliner und Munchener Tierarztliche Wochenschrift 91(24): 476-479
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Chlebowski, R.T.; Rohan, T.E.; Manson, J.E.; Aragaki, A.K.; Kaunitz, A.; Stefanick, M.L.; Simon, M.S.; Johnson, K.C.; Wactawski-Wende, J.; O'Sullivan, M.J.; Adams-Campbell, L.L.; Nassir, R.; Lessin, L.S.; Prentice, R.L. 2015: Breast Cancer After use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data from 2 Women's Health Initiative Randomized Clinical Trials JAMA Oncology 1(3): 296-305
Blankenstein, M.A.; Mulder, E.; Broerse, J.J.; Van Der Molen, H.J. 1980: Mammary gland estrogen receptors and plasma prolactin during estrogen enhanced rat mammary tumor development strain difference in the response to estrogen Radiation and Environmental Biophysics 17(4): 359
D'arcangues, C. 1991: Once-a-month estrogen/progestogen injectables Entre Nous 19: 15
Briggs, M.; Briggs, M. 1983: Oral contraceptives containing estrogen plus progestogen Benagiano, G And E Diczfalusy (Ed ) Comprehensive Endocrinology: Endocrine Mechanisms in Fertility Regulation Xi+354p Raven Press: New York, N Y , Usa Illus P17-48
Hertz, R.; Bailar, J.C. 1966: Estrogen-progestogen combinations for contraception JAMA 198(9): 1000-1006
Mottier, D.; Jouquan, J.; Baccino, E.; Cleuziou, A.; Pennec, Y.; Kerlan, V.; Garo, B.; Bergeret, G. 1984: Estrogen-progestogen agents and megaloblastic anemia Journal de Gynecologie Obstetrique et Biologie de la Reproduction 13(6): 707-710
Koetsawang, S.; Srisupandit, S.; Srivannaboon, S.; Bhiráleus, P. 1977: Comparative clinical trial of two oral contraceptives with a low--estrogen content Journal of the Medical Association of Thailand 60(8): 368-373
Lee, N.C.; Rubin, G.L. 1984: Breast cancer in postmenopausal estrogen-progestogen users Obstetrics and Gynecology 64(6): 832-834
Hempel, E.; Böhm, W.; Möller, R.; Carol, W.; Klinger, G.; Peiker, G. 1975: Use of the depot estrogen ethinylestradiol sulfate in the therapy of menopausal syndrome Zentralblatt für Gynakologie 97(13): 798-810
Hayakawa, A. 2001: Estrogen progestogen replacement therapy for hyperlipidemia in postmenopausal women Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 701-706